.svg)
Global reach
Supporting radiotherapy teams around the world
Medical Precision Group operates from Europe and the United States and works with specialized partners across international markets.
Our structure allows us to stay close to customers while supporting the regulatory, commercial and operational requirements of a global medical device business.
Our foundation
Built around a clear clinical need
Medical Precision was founded in the Netherlands to improve the way patients are marked for radiotherapy.
This led to the development of Comfort Marker 2.0, a dedicated medical device designed for controlled and consistent patient marking.
2017
Medical Precision founded
Our development
From innovation to international MedTech
Comfort Marker 2.0 achieved CE marking in Europe in 2021 and FDA clearance in the United States in 2022. Medical Precision also operates within an ISO 13485 certified quality management framework, supporting the development and commercialization of medical devices across international markets.
2021
CE marking achieved
2022
FDA clearance obtained
ISO 13485
Certified quality management system
2025 to 2026
US expansion
Medical Precision Inc. established and direct US operations launched from Arizona.
Medical Precision Group
One group. Two continents. One focus.
Medical Precision B.V. in Zwolle and Medical Precision Inc. in Arizona operate as one international group focused on the development, commercialization and support of medical technology for radiotherapy.
Europe
Zwolle, The Netherlands
European headquarters
United States
Arizona, USA
US headquarters
